Latest stories on OBIO
Orchestra BioMed to Host R&D Day Featuring Clinical Insights and Development Plans for AVIM Therapy and Virtue® SAB
Business Insider53 · neutralproduct/pr
OpenAI Acquires Orchestra Bio in Latest Push into Life Sciences
MarketWatch74 · bullishm&a
M&A News: OpenAI Acquires Orchestra Bio to Speed Up Drug Development with AI
TipRanks74 · bullishm&a
OpenAI acquires Orchestra Bio in AI push for new drugs
Seeking Alpha74 · bullishm&a
OpenAI confirms acquisition of biopharma platform Orchestra Bio
The Fly74 · bullishm&a
OpenAI acquires biotech startup Orchestra Bio, Axios reports
The Fly74 · bullishm&a
Piper Sandler reiterates Orchestra BioMed stock rating on AVIM trial
Investing.com Analyst Ratings50 · neutralanalyst
Orchestra BioMed Has A Clearer Trial Timeline But A Demanding Valuation
Seeking Alpha48 · neutralanalyst
Orchestra BioMed management to meet virtually with BTIG
The Fly56 · neutralgeneral
H.C. Wainwright reiterates Orchestra BioMed stock rating on trial enrollment
Investing.com Analyst Ratings56 · neutralanalyst
Orchestra BioMed Completes Enrollment in BACKBEAT AVIM Trial
TipRanks63 · neutralproduct/pr
Orchestra BioMed Holdings, Inc. (OBIO) files 8-K
SEC 8-K50 · neutralgeneral
Orchestra BioMed Exceeds Full Enrollment Target in the BACKBEAT Global Pivotal Trial of AVIM Therapy
Business Insider67 · bullishproduct/pr
Orchestra BioMed Exceeds Full Enrollment Target in the BACKBEAT Global Pivotal Trial of AVIM Therapy
GlobeNewswire67 · bullishproduct/pr
Orchestra BioMed management to meet virtually with Piper Sandler
The Fly55 · neutralgeneral
Codal to Expand into New Chicago Loop Headquarters
Business Insider63 · neutralproduct/pr
Orchestra BioMed Announces AVIM Therapy to Be Featured in Two Sessions at HRX Live 2026
Business Insider56 · neutralproduct/pr
Orchestra BioMed receives $6.1M milestone payment from Haemonetics
The Fly63 · neutralgeneral
Orchestra BioMed Receives $6.1 Million Milestone Payment from Acquisition of Vivasure by Haemonetics
GlobeNewswire63 · neutralm&a
Orchestra BioMed Receives $6.1 Million Milestone Payment from Acquisition of Vivasure by Haemonetics
StockTitan63 · neutralm&a
Orchestra BioMed price target raised to $11 from $10 at B. Riley
The Fly61 · neutralanalyst
These Two Healthcare Stocks Hit Key Milestones Today – Why Is Wall Street Bullish On Them?
Stocktwits News63 · neutralanalyst
BTIG upgrades Orchestra BioMed stock rating on trial progress
Investing.com Analyst Ratings63 · neutralanalyst